Cancer Chemotherapy, Immunotherapy, and Biotherapy - Bruce A. Chabner, Dan L. Longo

Cancer Chemotherapy, Immunotherapy, and Biotherapy

Buch | Softcover
720 Seiten
2024 | 7th edition
Wolters Kluwer Health (Verlag)
978-1-9751-9929-6 (ISBN)
249,40 inkl. MwSt
Focusing on individual patient needs, Cancer Chemotherapy, Immunotherapy and Biotherapy:  Principles and Practice, Seventh Edition, provides thorough, comprehensive information from Drs. Bruce A. Chabner, Dan L. Longo, and an authoritative team of clinicians and scientists working at renowned cancer centers across the globe. It covers fundamental information about mechanism of action, pharmacokinetics, clinical toxicity, and drug interactions, all essential to the safe and effective use of the drug.

Features full-color illustrations, numerous tables for quick reference and new content that brings you fully up to date with the state of the art in all current cancer therapies
Contains the latest information on immunotherapy and molecular targeted therapy as well as all drugs and biological agents, their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance
Reflects recent significant changes in cancer treatment, including new combination agents, new agents specifically related to CAR-T and checkpoint inhibitors, and new antibody conjugates
Explains the rationale for use of drugs in specific schedules and combinations and offers guidelines for dose adjustment in specific situations
Erscheinungsdatum
Sprache englisch
Maße 213 x 276 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 1-9751-9929-4 / 1975199294
ISBN-13 978-1-9751-9929-6 / 9781975199296
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99